Staying Up to Date with COVID-19 Vaccines and Boosters

Our risk of illness due to Covid-19 continues. Healthcare professionals are working to limit the spread of the virus to the point that it will become a simple matter of routine prevention. Vaccines and updated boosters are one method of reducing our own risk of illness, which in turn will hopefully reduce the risk of transmitting the virus to others.

2022-10-03T12:06:40-05:00October 5, 2022|

Illinois Department of Public Health Announces COVID-19 Antivirals Available in the Coming Weeks

The Illinois Department of Public Health (IDPH) is announcing two new COVID-19 oral antivirals, Paxlovid (Pfizer) and Molnupiravir (Merck), will be available in Illinois later this month. The antivirals are for those with mild-to-moderate COVID-19 who are at high risk for becoming severely ill, including hospitalization or death.

2022-01-19T17:21:42-06:00January 18, 2022|

CDC Recommends Pfizer Booster at 5 Months, Additional Primary Dose for Certain Immunocompromised Children

Today, CDC is updating our recommendation for when many people can receive a booster shot, shortening the interval from 6 months to 5 months for people who received the Pfizer-BioNTech COVID-19 Vaccine. This means that people can now receive an mRNA booster shot 5 months after completing their Pfizer-BioNTech primary series. The booster interval recommendation for people who received the J&J vaccine (2 months) or the Moderna vaccine (6 months), has not changed.

2022-01-19T17:26:23-06:00January 4, 2022|
Go to Top